TidalSense

TidalSense

Private
Cambridge, EnglandHealthcare & Life Scienceshttps://www.tidalsense.com

Last Round

Grant

Feb 6, 2025

Total Funding Raised

$10.63M

Momentum Score

50 /100

Company Overview

TidalSense is a healthcare technology company that develops AI-driven respiratory diagnostic and monitoring tools capable of detecting changes in lung function through real-time conversion of sensor data into respiratory biomarkers.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Sensors, Health IoT

Business Model

B2G

Customer Profile

Usage-Based SaaS, Hardware + Subscription, Government Contracts

AI Layer

Application

Keywords

COPD diagnosisAI medical devicerespiratory diagnosticsDiagnostic-as-a-ServiceDaaSpoint-of-care testingPOCTbreath analysisnon-invasive diagnosticsspirometry alternativelung function testpay-per-test modelprimary care diagnosticsCE-marked deviceclinical AIresptechbreathomics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

TidalSense Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

TidalSense Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantFeb 6, 2025
SeedMay 16, 2023
SeedApr 13, 2023

Key People

Founding team and executive leadership

Christian Faires CGMA ACMA

Chief Financial Officer

Executive Team

TidalSense Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 10, 2026

    Launched AI-driven diagnostic test for COPD using patented sensor technology.

  • Feb 3, 2026

    Seeking regulatory clearance for medical devices in USA, EU, Canada, and China.

TidalSense Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

TidalSense Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about TidalSense's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, England
Employee Range32
Year Founded2013
Last FundingFeb 6, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.